Nitric oxide short-circuits interleukin-12-mediated tumor regression

Cancer Immunology, Immunotherapy

Volumn 60, Issue 6, 2011, Pages 839-845

  Egilmez, Nejat K ^a   Harden, Jamie L ^a   Virtuoso, Lauren P ^a   Schwendener, Reto A ^b   Kilinc, Mehmet O ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

CD8+ T cell; Immune therapy; INOS; Interleukin 12; Nitric oxide; Tumor

Indexed keywords

CD11B ANTIGEN; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME REGULATION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL DEPLETION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY; TUMOR REGRESSION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; INJECTIONS, INTRALESIONAL; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; LYMPHOCYTES, TUMOR-INFILTRATING; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79959747137     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-011-0998-2     Document Type: Article

References (26)

1. G Trinchieri 2003 Interleukin-12 and the regulation of innate resistance and adaptive immunity Nat Rev Immunol 3 133 146 (Pubitemid 37328691)
2. K Tsung JB Meko GR Peplinski YL Tsung JA Norton 1997 IL-12 induces T helper 1-directed antitumor response J Immunol 158 3359 3365 (Pubitemid 127484054)
3. K Tsung JP Dolan YL Tsung JA Norton 2002 Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection Cancer Res 62 5069 5075 (Pubitemid 34984436)
4. SD Hess NK Egilmez N Bailey TM Anderson E Mathiowitz SH Bernstein RB Bankert 2003 Human CD4+ T cells present within the microenvironment of human lung tumors are mobilized by the local and sustained release of IL-12 to kill tumors in situ by indirect effects of IFN-γ J Immunol 170 400 412 (Pubitemid 36026165)
5. SK Watkins B Li KS Richardson K Head NK Egilmez Q Zeng J Suttles RD Stout 2009 Rapid release of cytoplasmic IL-15 from tumor-associated macrophages is an initial and critical event in IL-12 initiated tumor regression Eur J Immunol 39 1 19
6. J MacMicking QW Xie C Nathan 1997 Nitric oxide and macrophage function Annu Rev Immunol 15 323 350 (Pubitemid 27169284)
7. S Mocellin V Bronte D Nitti 2007 Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities Med Res Rev 27 317 352 (Pubitemid 46668937)
8. WA Paradise BJ Vesper A Goel JD Waltonen KW Altman GK Haines III JA Radosevich 2010 Nitric oxide: perspectives and emerging studies of a well known cytotoxin Int J Mol Sci 11 2715 2745
9. L Morbidelli S Donnini M Ziche 2004 Role of nitric oxide in tumor angiogenesis Cancer Treat Res 117 155 167
10. D Fukumura S Kashiwagi RK Jain 2006 The role of nitric oxide in tumour progression Nature Rev Cancer 6 521 534 (Pubitemid 43980541)
11. A Siegert C Rosenberg WD Schmitt C Denkert S Hauptmann 2002 Nitric oxide of human colorectal adenocarcinoma cell lines promotes tumour cell invasion Br J Cancer 86 1310 1315
12. LC Jadeski C Chakraborty PK Lala 2003 Nitric oxide-mediated promotion of mammary tumour cell migration requires sequential activation of nitric oxide synthase, guanylate cyclase and mitogen-activated protein kinase Int J Cancer 106 496 504 (Pubitemid 36966204)
13. H Kurzawa Koblish CA Hunter M Wysocka G Trinchieri WMF Lee 1998 Immune suppression by recombinant interleukin (rIL)-12 involves interferon γ induction of nitric oxide synthase 2 (iNOS) activity: inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect J Exp Med 188 1603 1610 (Pubitemid 28516105)
14. M Medot-Pirenne MJ Heilman M Saxena PE McDermott CD Mills 1999 Augmentation of an antitumor CTL response in vivo by inhibition of suppressor macrophage nitric oxide J Immunol 163 587 5882
15. A Mazzoni V Bronte A Visintin JH Spitzer E Apolloni P Serafini P Zanovello DM Segal 2002 Myeloid suppressor lines inhibit T cell responses by an NO-dependent mechanism J Immunol 168 689 695 (Pubitemid 34049569)
16. M McLean HL Wallace A Sharma HC Hill MS Sabel NK Egilmez 2004 A murine surgical metastasis model for the evaluation of anti-cancer strategies Clin Exp Metastasis 21 4 363 369
17. MO Kilinc KS Aulakh RE Nair SA Jones II P Alard MM Kosiewicz NK Egilmez 2006 Reversing tumor immune suppression with intra-tumoral IL-12: activation of tumor-associated T-effector/memory cells, induction of T-suppressor apoptosis and infiltration of CD8+ T-effectors J Immunol 177 6962 6973 (Pubitemid 44715062)
18. RE Nair MO Kilinc SA Jones NK Egilmez 2006 Chronic immune therapy induces a progressive increase in intra-tumoral T-suppressor activity and a concurrent loss of tumor-specific CD8+ T-effectors in her-2/neu transgenic mice bearing advanced spontaneous tumors J Immunol 176 12 7325 7334 (Pubitemid 43849033)
19. T Gu MO Kilinc NK Egilmez 2008 Transient activation of tumor-associated T-effector/memory cells promotes tumor eradication via NK-cell recruitment: minimal role for long-term T-cell immunity in cure of metastatic disease Cancer Immunol Immunother 57 7 997 1005
20. SM Zeisberger B Odermatt C Marty AH Zehnder-Fjällman K Ballmer-Hofer RA Schwendener 2006 Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach Br J Cancer 95 3 272 281 (Pubitemid 44187587)
21. MO Kilinc T Gu JL Harden LP Virtuoso NK Egilmez 2009 Central role of tumor-associated CD8+ T effector/memory cells in restoring systemic antitumor immunity J Immunol 182 4217 4225
22. A Sica P Larghi A Mancino L Rubino C Porta M Grazia Totaro M Rimoldi S Kumar Biswas P Allavena A Mantovani 2008 Macrophage polarization in tumour progression Sem Cancer Biol 18 349 355
23. K Movahedi D Laoui C Gysemans M Baeten G Stangé J Van den Bossche M Mack D Pipeleers P In't Veld P De Baetselier JA Van Ginderachter 2010 Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes Cancer Res 70 5728 5739
24. O Gallo, et al. 1998 Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer J Natl Cancer Inst 90 584 596
25. G-nitro-l-arginine methyl ester inhibits tumor-induced angiogenesis in mammary tumors Am J Pathol 155 1381 1390 (Pubitemid 29488945)
26. M Del Vecchio E Bajetta S Conova MT Lotze A Wesa G Parmiani A Anichini 2007 Interleukin-12: biological properties and clinical application Clin Cancer Res 13 16 4677 4685 (Pubitemid 47294773)